Radiotherapy & Oncology
Volume 95, Issue 3 , Pages 277-282 , June 2010

Is there a role for endorectal balloons in prostate radiotherapy? A systematic review

  • Robert Jan Smeenk

      Affiliations

    • Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    • Corresponding Author InformationCorresponding author. Address: Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.
    • ,
  • Bin S. Teh

      Affiliations

    • Department of Radiation Oncology, The Methodist Hospital and The Methodist Hospital Research Institute, Houston, TX, USA
    • ,
  • E. Brian Butler

      Affiliations

    • Department of Radiation Oncology, The Methodist Hospital and The Methodist Hospital Research Institute, Houston, TX, USA
    • ,
  • Emile N.J.Th. van Lin

      Affiliations

    • Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    • ,
  • Johannes H.A.M. Kaanders

      Affiliations

    • Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

Received 16 June 2009 ,Revised 21 January 2010 ,Accepted 7 April 2010.

References 

  1. Hanks GE, Hanlon AL, Epstein B, Horwitz EM. Dose response in prostate cancer with 8–12 years’ follow-up. Int J Radiat Oncol Biol Phys. 2002;54:427–435
  2. Zelefsky MJ, Fuks Z, Hunt M, et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol. 2001;166:876–881
  3. Kuban D, Pollack A, Huang E, et al. Hazards of dose escalation in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys. 2003;57:1260–1268
  4. Bacon CG, Giovannucci E, Testa M, Glass TA, Kawachi I. The association of treatment-related symptoms with quality-of-life outcomes for localized prostate carcinoma patients. Cancer. 2002;94:862–871
  5. Dearnaley DP, Khoo VS, Norman AR, et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet. 1999;353:267–272
  6. Zelefsky MJ, Fuks Z, Hunt M, et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys. 2002;53:1111–1116
  7. De Meerleer G, Vakaet L, Meersschout S, et al. Intensity-modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients. Int J Radiat Oncol Biol Phys. 2004;60:777–787
  8. De Meerleer GO, Fonteyne VH, Vakaet L, et al. Intensity-modulated radiation therapy for prostate cancer: late morbidity and results on biochemical control. Radiother Oncol. 2007;82:160–166
  9. Zelefsky MJ, Levin EJ, Hunt M, et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008;70:1124–1129
  10. Langen KM, Jones DT. Organ motion and its management. Int J Radiat Oncol Biol Phys. 2001;50:265–278
  11. Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P. Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer. 2000;89:1800–1809
  12. Van Lin EN, van der Vight LP, Witjes JA, Huisman HJ, Leer JW, Visser AG. The effect of an endorectal balloon and off-line correction on the interfraction systematic and random prostate position variations: a comparative study. Int J Radiat Oncol Biol Phys. 2005;61:278–288
  13. Moseley DJ, White EA, Wiltshire KL, et al. Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate. Int J Radiat Oncol Biol Phys. 2007;67:942–953
  14. D’Amico AV, Manola J, Loffredo M, et al. A practical method to achieve prostate gland immobilization and target verification for daily treatment. Int J Radiat Oncol Biol Phys. 2001;51:1431–1436
  15. Wachter S, Gerstner N, Dorner D, et al. The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2002;52:91–100
  16. McGary JE, Grant W. A clinical evaluation of setup errors for a prostate immobilization system. J Appl Clin Med Phys. 2000;1:138–147
  17. McGary JE, Teh BS, Butler EB, Grant W. Prostate immobilization using a rectal balloon. J Appl Clin Med Phys. 2002;3:6–11
  18. Teh BS, Mai WY, Uhl BM, et al. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis. Int J Radiat Oncol Biol Phys. 2001;49:705–712
  19. Teh BS, McGary JE, Dong L, et al. The use of rectal balloon during the delivery of intensity modulated radiotherapy (IMRT) for prostate cancer: more than just a prostate gland immobilization device?. Cancer J. 2002;8:476–483
  20. Teh BS, Woo SY, Mai WY, et al. Clinical experience with intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of rectal balloon for prostate immobilization. Med Dosim. 2002;27:105–113
  21. Ciernik IF, Baumert BG, Egli P, Glanzmann C, Lütolf UM. On-line correction of beam portals in the treatment of prostate cancer using an endorectal balloon device. Radiother Oncol. 2002;65:39–45
  22. Patel RR, Orton N, Tomé WA, Chappell R, Ritter MA. Rectal dose sparing with a balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancer. Radiother Oncol. 2003;67:285–294
  23. Sanghani MV, Ching J, Schultz D, et al. Impact on rectal dose from the use of a prostate immobilization and rectal localization device for patients receiving dose escalated 3D conformal radiation therapy. Urol Oncol. 2004;22:165–168
  24. Van Lin EN, Hoffmann AL, van Kollenburg P, Leer JW, Visser AG. Rectal wall sparing effect of three different endorectal balloons in 3D conformal and IMRT prostate radiotherapy. Int J Radiat Oncol Biol Phys. 2005;63:565–576
  25. Van Lin EN, Kristinsson J, Philippens ME, et al. Reduced late rectal mucosal changes after prostate three-dimensional conformal radiotherapy with endorectal balloon as observed in repeated endoscopy. Int J Radiat Oncol Biol Phys. 2007;67:799–811
  26. Hille A, Schmidberger H, Töws N, Weiss E, Vorwerk H, Hess CF. The impact of varying volumes in rectal balloons on rectal dose sparing in conformal radiation therapy of prostate cancer. A prospective three-dimensional analysis. Strahlenther Onkol. 2005;181:709–716
  27. Elsayed H, Bölling T, Moustakis C, et al. Organ movements and dose exposures in teletherapy of prostate cancer using a rectal balloon. Strahlenther Onkol. 2007;183:617–624
  28. Vlachaki MT, Teslow TN, Amosson C, Uy NW, Ahmad S. IMRT versus conventional 3DCRT on prostate and normal tissue dosimetry using an endorectal balloon for prostate immobilization. Med Dosim. 2005;30:69–75
  29. Shipley WU, Tepper JE, Prout GR, et al. Proton radiation as boost therapy for localized prostatic carcinoma. JAMA. 1979;241:1912–1915
  30. Court LE, D’Amico AV, Kadam D, Cormack R. Motion and shape change when using an endorectal balloon during prostate radiation therapy. Radiother Oncol. 2006;81:184–189
  31. Vargas C, Mahajan C, Fryer A, et al. Rectal dose-volume differences using proton radiotherapy and a rectal balloon or water alone for the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 2007;69:1110–1116
  32. Teh BS, Dong L, McGary JE, Mai WY, Grant W, Butler EB. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer. Med Dosim. 2005;30:25–30
  33. Smeenk RJ, van Lin EN, Van Kollenburg P, Kunze-Busch M, Kaanders JH. Anal wall sparing effect of an endorectal balloon in 3D conformal and intensity-modulated prostate radiotherapy. Radiother Oncol. 2009;93:131–136
  34. El-Bassiouni M, Davis JB, El-Attar I, Studer GM, Lütolf UM, Ciernik IF. Target motion variability and on-line positioning accuracy during external-beam radiation therapy of prostate cancer with an endorectal balloon device. Strahlenther Onkol. 2006;182:531–536
  35. Miralbell R, Mollà M, Arnalte R, et al. Target repositioning optimization in prostate cancer: is intensity-modulated radiotherapy under stereotactic conditions feasible?. Int J Radiat Oncol Biol Phys. 2004;59:366–371
  36. Garg AK, Mai WY, McGary JE, Grant WH, Butler EB, Teh BS. Radiation proctopathy in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 2006;66:1294–1305
  37. Tucker SL, Zhang M, Dong L, Mohan R, Kuban D, Thames HD. Cluster model analysis of late rectal bleeding after IMRT of prostate cancer: a case-control study. Int J Radiat Oncol Biol Phys. 2006;64:1255–1264
  38. Li XA, Yu C, Holmes T. A systematic evaluation of air cavity dose perturbation in megavoltage x-ray beams. Med Phys. 2000;27:1011–1017
  39. Ebert MA, Spry NA. Dose perturbation by air cavities in megavoltage photon beams: implications for cavity surface doses. Australas Radiol. 2001;45:205–210
  40. Goldner G, Tomicek B, Becker G, et al. Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC/RTOG score for late rectal toxicity: results of a prospective multicenter study of 166 patients. Int J Radiat Oncol Biol Phys. 2007;67:78–83
  41. Goldner G, Bombosch V, Geinitz H, et al. Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74Gy. First report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial. Strahlenther Onkol. 2009;185:94–100
  42. Woel R, Beard C, Chen MH, et al. Acute gastrointestinal, genitourinary, and dermatological toxicity during dose-escalated 3D-conformal radiation therapy (3DCRT) using an intrarectal balloon for prostate gland localization and immobilization. Int J Radiat Oncol Biol Phys. 2005;62:392–396
  43. D’Amico AV, Manola J, McMahon E, et al. A prospective evaluation of rectal bleeding after dose-escalated three-dimensional conformal radiation therapy using an intrarectal balloon for prostate gland localization and immobilization. Urology. 2006;67:780–784
  44. Slater JD, Rossi CJ, Yonemoto LT, et al. Proton therapy for prostate cancer: the initial Loma Linda University experience. Int J Radiat Oncol Biol Phys. 2004;59:348–352
  45. Teh BS, Mai WY, Augspurger ME, et al. Intensity modulated radiation therapy (IMRT) following prostatectomy: more favorable acute genitourinary toxicity profile compared to primary IMRT for prostate cancer. Int J Radiat Oncol Biol Phys. 2001;49:465–472
  46. Goldner G, Geinitz H, Wachter S, et al. 3-D Conformal radiotherapy of localized prostate cancer within an Austrian-German multicenter trial: a prospective study of patients’ acceptance of the rectal balloon during treatment. Wien Klin Wochenschr. 2006;118:224–229
  47. Bastasch MD, Teh BS, Mai WY, McGary JE, Grant WH, Butler EB. Tolerance of endorectal balloon in 396 patients treated with intensity-modulated radiation therapy (IMRT) for prostate cancer. Am J Clin Oncol. 2006;29:8–11
  48. Ronson BB, Yonemoto LT, Rossi CJ, Slater JM, Slater JD. Patient tolerance of rectal balloons in conformal radiation treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 2006;64:1367–1370
  49. Wang CW, Chong FC, Lai MK, Pu YS, Wu JK, Cheng JC. Set-up errors due to endorectal balloon positioning in intensity modulated radiation therapy for prostate cancer. Radiother Oncol. 2007;84:177–184
  50. Heijmink SW, Scheenen TW, van Lin EN, et al. Changes in prostate shape and volume and their implications for radiotherapy after introduction of endorectal balloon as determined by MRI at 3T. Int J Radiat Oncol Biol Phys. 2009;73:1446–1453
  51. Ahmad S, Vlachaki MT, Teslow TN, et al. Impact of setup uncertainty in the dosimetry of prostate and surrounding tissues in prostate cancer patients treated with Peacock/IMRT. Med Dosim. 2005;30:1–7
  52. Vlachaki MT, Teslow TN, Ahmad S. Impact of endorectal balloon in the dosimetry of prostate and surrounding tissues in prostate cancer patients treated with IMRT. Med Dosim. 2007;32:281–286
  53. Song JS, Court LE, Cormack RA. Monte Carlo calculation of rectal dose when using an intrarectal balloon during prostate radiation therapy. Med Dosim. 2007;32:151–156
  54. Langen KM, Willoughby TR, Meeks SL, et al. Observations on real-time prostate gland motion using electromagnetic tracking. Int J Radiat Oncol Biol Phys. 2008;71:1084–1090
  55. Mollà M, Escude L, Nouet P, et al. Fractionated stereotactic radiotherapy boost for gynecologic tumors: an alternative to brachytherapy?. Int J Radiat Oncol Biol Phys. 2005;62:118–124

PII: S0167-8140(10)00242-2

doi: 10.1016/j.radonc.2010.04.016

Radiotherapy & Oncology
Volume 95, Issue 3 , Pages 277-282 , June 2010

Article Tools

* Image Usage & Resolution